Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Interventional × mogamulizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 12 OTHER 11 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Radiotherapy 253 Cisplatin 233 Cyclophosphamide 190 Doxorubicin 145 Paclitaxel 142 Carboplatin 131 Vincristine 128 Etoposide 117 Filgrastim 112 Fluorouracil 101 Gemcitabine 100 Docetaxel 95 Dexamethasone 88 Methotrexate 86 Cytarabine 85 Leucovorin 77 Prednisone 73 Granulocyte Colony-Stimulating Factor 59 Capecitabine 53 Irinotecan 49 Radiation 46 Oxaliplatin 46 Ifosfamide 46 Magnetic Resonance Spectroscopy 45 Specimen Handling 44 Radiotherapy, Conformal 42 Platinum 42 Daunorubicin 40 Temozolomide 39 Peripheral Blood Stem Cell Transplantation 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04128072 2024-04-05

MOGAT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡